Breast cancer. Breast, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Randomize; obtaining informed consent; patients with non-metastatic disease (level 1 to 3); completed treatment with chemotherapy and radiotherapy (at least one month); patients with estrogen and progesterone receptors. Exclusion criteria: patients with tobacco and alcohol consumption; patients with unwillingness to exercise; patients with serious acute and chronic heart failure; patients with serious chronic respiratory failure; patients with chronic liver failure; patients with metastatic disease to bone and brain.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of miR-21. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-222. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-155. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-let7. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-143. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-145. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-206. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-221. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime.;Serum level of miR-200. Timepoint: Before and after of exercise. Method of measurement: QPCR-Real Ttime. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences